These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2999656)

  • 21. Definition of receptors in radioligand-binding experiments.
    Keen M
    Methods Mol Biol; 1999; 106():187-96. PubMed ID: 9921505
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantifying receptor properties: the tissue segment binding method - a powerful tool for the pharmacome analysis of native receptors.
    Muramatsu I; Tanaka T; Suzuki F; Li Z; Hiraizumi-Hiraoka Y; Anisuzzaman AS; Yamamoto H; Horinouchi T; Morishima S
    J Pharmacol Sci; 2005 Aug; 98(4):331-9. PubMed ID: 16082176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved receptor analysis in PET using a priori information from in vitro binding assays.
    Litton JE; Hall H; Blomqvist G
    Phys Med Biol; 1997 Aug; 42(8):1653-60. PubMed ID: 9279912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide hormone receptors.
    Catt KJ; Dufau ML
    Annu Rev Physiol; 1977; 39():529-57. PubMed ID: 15500
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro muscarinic receptor radioligand-binding assays.
    Steinfeld T; Pulido-Rios MT; Armstrong S; Hegde SS
    Curr Protoc Pharmacol; 2010 Mar; Chapter 1():Unit 1.33. PubMed ID: 22294363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioligand saturation binding experiments over large concentration ranges.
    Bylund DB; Murrin LC
    Life Sci; 2000 Nov; 67(24):2897-911. PubMed ID: 11133002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometry: a novel approach for the quantitative analysis of receptor--ligand interactions on surfaces of living cells.
    Bohn B
    Mol Cell Endocrinol; 1980 Oct; 20(1):1-15. PubMed ID: 6254819
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-Hydroxytryptamine, histamine and N-acetyl-histamine in the nervous system of Dosidicus gigas.
    Roseghini M; Ramorino LM
    J Neurochem; 1970 Apr; 17(4):489-92. PubMed ID: 4392649
    [No Abstract]   [Full Text] [Related]  

  • 29. Topographically designed analogues of [D-Pen,D-Pen5]enkephalin.
    Hruby VJ; Toth G; Gehrig CA; Kao LF; Knapp R; Lui GK; Yamamura HI; Kramer TH; Davis P; Burks TF
    J Med Chem; 1991 Jun; 34(6):1823-30. PubMed ID: 1648137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and SAR analysis of novel selective sigma1 ligands.
    Collina S; Loddo G; Urbano M; Linati L; Callegari A; Ortuso F; Alcaro S; Laggner C; Langer T; Prezzavento O; Ronsisvalle G; Azzolina O
    Bioorg Med Chem; 2007 Jan; 15(2):771-83. PubMed ID: 17088069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Means for the assessment of radioligand quality and its importance in receptor-binding studies. Observations with radiolabelled formylmethionyl-leucyl-phenylalanine.
    Kermode JC
    Biochem J; 1988 Jun; 252(2):521-8. PubMed ID: 2843171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Displacement reactions employing heterologous tracer ligands in peptide receptor studies: a review.
    Pliska V
    J Recept Res; 1983; 3(1-2):227-38. PubMed ID: 6304300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynorphin and dynorphin are ligands for the kappa-subtype of opiate receptor.
    Corbett AD; Paterson SJ; McKnight AT; Magnan J; Kosterlitz HW
    Nature; 1982 Sep; 299(5878):79-81. PubMed ID: 6125893
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
    Leach K; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Method and program for evaluating and correcting the parameters characterizing hormone-receptor interaction].
    Shisheva A; Vrabchev N; Sirakov L
    Eksp Med Morfol; 1985; 24(3):49-56. PubMed ID: 2998724
    [No Abstract]   [Full Text] [Related]  

  • 37. Receptor binding: a tool to aid in determining the role of peptides in behavior.
    Creese I
    Neurosci Res Program Bull; 1978 Dec; 16(4):498-509. PubMed ID: 220553
    [No Abstract]   [Full Text] [Related]  

  • 38. Quinazolinone derivatives: synthesis and binding evaluation on cholecystokinin receptors.
    Varnavas A; Lassiani L; Luxich E; Zacchigna M; Boccù E
    Farmaco; 1996 May; 51(5):333-9. PubMed ID: 8767843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High throughput fluorescence polarization: a homogeneous alternative to radioligand binding for cell surface receptors.
    Allen M; Reeves J; Mellor G
    J Biomol Screen; 2000 Apr; 5(2):63-9. PubMed ID: 10803605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current research trends in radioreceptor assay--human thyroid gland TSH receptor].
    Ichikawa Y; Abe Y; Saito E; Kawagoe M; Yoshida K
    Nihon Rinsho; 1976 Jun; 34(6):1309-12. PubMed ID: 184315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.